Literature DB >> 12685846

Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral vein.

Tali Cukierman1, Moshe E Gatt, Dianna Libster, Neta Goldschmidt, Yaacov Matzner.   

Abstract

Very few case reports dealing with chronic lymphocytic leukemia (CLL) and hyperleukocytosis have been reported in the medical literature and none with venous thrombosis as a complication. Here, we describe a 73-year-old woman who presented with newly diagnosed CLL, leukostasis, and hyperleukocytosis (2000 x 10(9)/l), affecting the respiratory and nervous system. In addition, she also had deep vein thrombosis (DVT). Although hypercoagulability and thrombosis are well-described phenomena in solid tumors and in myeloproliferative neoplasms, CLL is generally not associated with an acquired coagulopathy. We hypothesize that in our patient the extreme number of circulating lymphocytes resulted in an abnormal accumulation of lymphocytes possibly causing stasis and occlusion of a larger vessel, which resolved after leukopheresis. The patient has since been successfully maintained with chemotherapy. We conclude that leukopheresis should be considered as the therapy of choice in CLL patients presenting with major complications of leukostasis.

Entities:  

Mesh:

Year:  2002        PMID: 12685846     DOI: 10.1080/1042819021000006367

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.

Authors:  Dianne Pulte; Richard R Furman; M Johan Broekman; Joan H F Drosopoulos; Harold S Ballard; Kim E Olson; Jorge R Kizer; Aaron J Marcus
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-08

2.  A case of leukemia cutis presenting as blue toes in a patient with chronic lymphocytic leukemia.

Authors:  Joseph Caravaglio; Rachel Wheatley; Molly Orban; Jeffrey Greenwald
Journal:  JAAD Case Rep       Date:  2016-04-22

3.  An unusual presentation of chronic lymphocytic leukemia.

Authors:  Dinesh Atwal; Mihir Raval; Belal Firwana; Jeanette Ramos; Appalanaidu Sasapu
Journal:  Avicenna J Med       Date:  2017 Jul-Sep

4.  Leukostasis in Chronic Lymphocytic Leukemia.

Authors:  Navdeep Singh; Sandeep Singh Lubana; Lech Dabrowski; Gurinder Sidhu
Journal:  Am J Case Rep       Date:  2020-07-03

5.  CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.

Authors:  Dianne Pulte; Kim E Olson; M Johan Broekman; Naziba Islam; Harold S Ballard; Richard R Furman; Ashley E Olson; Aaron J Marcus
Journal:  J Transl Med       Date:  2007-05-04       Impact factor: 5.531

6.  Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.

Authors:  S E M Herman; C U Niemann; M Farooqui; J Jones; R Z Mustafa; A Lipsky; N Saba; S Martyr; S Soto; J Valdez; J A Gyamfi; I Maric; K R Calvo; L B Pedersen; C H Geisler; D Liu; G E Marti; G Aue; A Wiestner
Journal:  Leukemia       Date:  2014-04-04       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.